IGM MGUS

Clinical trials for IGM MGUS explained in plain language.

Never miss a new study

Get alerted when new IGM MGUS trials appear

Sign up with your email to follow new studies for IGM MGUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug combo aims to halt debilitating nerve damage

Disease control Ongoing

This study is testing whether combining the drug acalabrutinib with an antibody treatment (like rituximab) is safe and effective for people with nerve damage (neuropathy) caused by specific blood conditions. The goal is to control the underlying disease and improve or stabilize n…

Matched conditions: IGM MGUS

Phase: PHASE2 • Sponsor: Shayna Sarosiek, MD • Aim: Disease control

Last updated Mar 25, 2026 14:08 UTC

IGM MGUS

Get alerted when new IGM MGUS trials appear

New drug combo aims to halt debilitating nerve damage